Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease-Reference-Cited by-同舟云学术

Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease

Published:2018-01-10 Issue:6 Volume:34 Page:1021-1027
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Huang Huan¹^ORCID,Shetty Sharash²,Bauer Elise¹,Lang Kathleen¹

Affiliation:

1. IQVIA (Formerly QuintilesIMS), Cambridge, MA, USA;

2. Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1416346

Reference26 articles.

1. Management of type 2 diabetes mellitus in the elderly

2. Challenges in the Management of Type 2 Diabetes in the Elderly

3. Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System – United States. Available at: https://nccd.cdc.gov/ckd/detail.aspx?QNum=Q9&Strat=Diabetes [Last accessed 20 April 2017]

4. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

5. Diabetes therapies in renal impairment

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease;Endocrinology and Metabolism;2024-08-31

2. Cumplimiento de las recomendaciones de ajuste de la dosis de inhibidores DPP4 según la función renal en una base de datos poblacional;Endocrinología, Diabetes y Nutrición;2022-02

3. Compliance with the DPP-4 inhibitors dose adjustment recommendations based on renal function in a population database;Endocrinología, Diabetes y Nutrición (English ed.);2022-02

4. Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney disease;Journal of Diabetes;2020-06-25

5. Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study;BMJ Open;2019-10